Dedicare (DEDI) Q1 2025 earnings summary

Executive summary

• Net sales fell 18.3% year-over-year to SEK 351.5 million in Q1 2025, with all markets weakening, especially Sweden.

• EBITA dropped 40.2% to SEK 10.4 million, with a margin of 3.0% (4.0%), mainly due to price pressure and higher payroll expenses.

• Dedicare increased market share in a declining market and launched further cost-saving programs targeting SEK 17 million annual savings.

• The group remains financially stable, with an equity/assets ratio of 48.4% at quarter-end.

Financial highlights

• Net sales: SEK 351.5 million (430.2), down 18.3% year-over-year.

• EBITA: SEK 10.4 million (17.4), EBITA margin 3.0% (4.0%).

• EBIT: SEK 8.0 million (15.1), EBIT margin 2.3% (3.5%).

• Net profit: SEK 6.9 million (10.5); basic EPS SEK 0.72 (1.09).

• Cash flow from operating activities: SEK 39.4 million (21.6).

Outlook and guidance

• No signs of improvement in the healthcare staffing market so far in 2025.

• Dedicare is positioned to exploit opportunities in growing segments like life science.

• Full effect of new cost savings program expected from Q4 2025.